LSD1 and SNAIL as well as their co-expression, can be used as a marker for poor prognosis and tumor progression in HNSCC of the hypopharynx, and screening intervals of tumors with high expression could be adjusted accordingly. Here, SNAI1 is linked to neoplasm.